13 篇
Polaris Pharmaceuticals-KY (6550) announced on May 15, 2026, the appointment of new members to its Remuneration Committee following the annual general meeting's re-election of directors. The changes are due to the completion of the previous term and the comprehensive re-election of directors, including independent directors. The new committee members are Zhao Yingcheng, Di Shijie, and Zhang Zhigang.
Polaris Pharmaceuticals-KY (6550) announced a change in its Audit Committee members following the full re-election of directors (including independent directors) at the company's 2026 Annual General Meeting. The term for the previous independent directors expired, leading to the appointment of new members. Zhao Ying-Cheng, who was an independent director, has been re-appointed. New independent directors include Zhang Yi-Fang (Vice President of Mackay Mackay Taitung Branch), Zhang Zhi-Gang (CEO of Zhongen Biomedical), and Di Shi-Jie (Associate Professor at the University of Hong Kong). Zhao Ying-Cheng's brief biography is listed as former TSMC Plant Manager.
This announcement from Polaris Pharmaceuticals-KY (stock code 6550) on May 15, 2026, states that the board of directors re-elected Chen Xian-Zhe as Chairman. This change is due to the expiration of his term. The event is considered to have a significant impact on shareholder equity or stock prices.
Polaris Pharmaceuticals-KY announced that its shareholders' meeting on May 15, 2026, approved the lifting of non-competition restrictions for new directors. The approved non-competition waiver allows directors to invest in or operate businesses that are the same as or similar to Polaris Pharmaceuticals-KY's business scope, effective immediately until their term ends. This decision was passed during the shareholders' meeting on May 15, 2026.
Polaris Pharmaceuticals-KY (6550) announced the results of its 115th annual general meeting of shareholders, which included the full re-election of directors (including independent directors). The changes are due to the expiration of the current term. Several new directors and independent directors have been appointed, with some incumbents also re-elected. The meeting took place on May 15, 115 (2026).
This announcement from CPC Corporation (1314) details a change in the representative of its corporate director at its subsidiary, Dingyue Development Co., Ltd. Zhou Zhiming, the former representative and Chairman of China Engineering Consultants, Inc., has resigned due to personal reasons. A new representative is pending appointment. This change, effective May 19, 115 (2026), constitutes a one-third change in the board for the current term.
Yuanta Financial Holding announced on May 15, 2026, that its subsidiary, Yuanta Savings Bank (Philippines), has reappointed its Audit Committee members due to the expiration of their terms. The reappointment includes Senen L. Matoto and Arturo E. Manuel, Jr. as Independent Directors, and Hsiao Chi-Liang as Director. The new term begins on May 15, 2026.
Yuan Ta Financial Holding announced that its subsidiary, Yuanta Savings Bank (Philippines), has re-elected Wu Jing-tang as its chairman. This appointment is due to the expiration of his term. Wu Jing-tang previously served as the Executive Vice President of Yuan Ta Bank.
Yuan Ta Financial Holding announced on May 15, 2025, that the terms of several directors and independent directors of its subsidiary, Yuan Ta Savings Bank (Philippines), have expired. The individuals re-appointed to their positions are Wu Jing-Tang, Lei Zhen-Na, and Xiao Ji-Liang as Directors, and Senen L. Matoto and Arturo E. Manuel, Jr. as Independent Directors. The re-appointments are effective May 15, 2025, and the previous terms ran from May 15, 2023, to May 14, 2025. This change is due to the expiration of their terms and does not constitute a significant change in the board composition.
Zhaoden-KY (4190) announced a change in its accounting firm due to internal rotation policies at the accounting firm. The new accounting firm and lead auditors remain the same for the most part, with one new auditor appointed. This change is in compliance with Article 7 of the relevant regulations. The company has not had any significant adjustments or recommendations from its previous auditor that it disagreed with.
國泰期貨公告了其於2026年5月12日召開的第115屆股東常會的重要決議。決議事項包括批准2025年度盈餘分配、營業報告、財務報表，以及董事監事的選舉。
元大金控代子公司元大證券公告，其於115年4月30日召開董事會，會中通過修正公司章程部分條文。
Synergy announced that its major subsidiary, Sung Da Optoelectronics Technology Co., Ltd., held a shareholder meeting on April 30, 115. The meeting approved the waiver of non-compete restrictions for newly appointed directors, including Lin Yishan, Wang Cao Zhengxiong, and Chen Xiaoguang, allowing them to engage in similar business activities during their tenure.